{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T02:03:26Z","timestamp":1784945006478,"version":"3.55.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jaad.2013.06.040","type":"journal-article","created":{"date-parts":[[2013,9,12]],"date-time":"2013-09-12T22:57:01Z","timestamp":1379026621000},"page":"513.e1-513.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Kawasaki disease"],"prefix":"10.1016","volume":"69","author":[{"given":"Stephanie","family":"Bayers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanford T.","family":"Shulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"Paller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.06.040_bib1","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jaad.2013.06.040_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0022-3476(05)81894-3","article-title":"Outcome of coronary artery aneurysms after Kawasaki disease","volume":"121","author":"Akagi","year":"1992","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2007-1025272","article-title":"Coronary aneurysm in Kawasaki syndrome: incidence and prognosis [in German]","volume":"201","author":"Beitzke","year":"1989","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib4","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1089\/ars.2012.4660","article-title":"Does oxidative stress play a critical role in cardiovascular complications of Kawasaki disease?","volume":"17","author":"Straface","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jaad.2013.06.040_bib5","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s00246-012-0327-3","article-title":"Kawasaki disease: a rare case of diffuse coronary involvement","volume":"33","author":"Gupta","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jaad.2013.06.040_bib6","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1097\/INF.0b013e31826108c2","article-title":"Infliximab treatment of pancreatitis complicating acute kawasaki disease","volume":"31","author":"Jimenez-Fernandez","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2013.06.040_bib7","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00246-012-0223-x","article-title":"Single-nucleotide polymorphism rs2290692 in the 3\u2032UTR of ITPKC associated with susceptibility to Kawasaki disease in a Han Chinese population","volume":"33","author":"Peng","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jaad.2013.06.040_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s12098-011-0552-4","article-title":"Symptomatic myocarditis in Kawasaki disease","volume":"79","author":"Aggarwal","year":"2012","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00247-012-2478-z","article-title":"Acquired coronary disease in children: the role of multimodality imaging","volume":"43","author":"Ou","year":"2013","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jaad.2013.06.040_bib10","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/01.CIR.94.6.1379","article-title":"Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients","volume":"94","author":"Kato","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jaad.2013.06.040_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF02315475","article-title":"Coronary arterial lesions of Kawasaki disease: cardiac\u00a0catheterization findings of 1100 cases","volume":"7","author":"Suzuki","year":"1986","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jaad.2013.06.040_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1546-0096-10-28","article-title":"Catastrophic Kawasaki disease unresponsive to IVIG in a 3-month-old infant: a diagnostic and therapeutic challenge","volume":"10","author":"Magalhaes","year":"2012","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jaad.2013.06.040_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pedneo.2011.11.003","article-title":"Kawasaki disease: an update on diagnosis and treatment","volume":"53","author":"Kuo","year":"2012","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/j.jaad.2013.06.040_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/01.inf.0000134312.39744.a4","article-title":"Failure to diagnose Kawasaki disease at the extremes of the pediatric age range","volume":"23","author":"Pannaraj","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2013.06.040_bib15","first-page":"387","article-title":"Kawasaki disease in infants three months of age or younger","volume":"39","author":"Chuang","year":"2006","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jaad.2013.06.040_bib16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0022-3476(86)80689-8","article-title":"Clinical spectrum of Kawasaki disease in infants younger than 6 months of age","volume":"109","author":"Burns","year":"1986","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib17","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0022-3476(95)70344-6","article-title":"Kawasaki disease in infants less than one year of age","volume":"126","author":"Rosenfeld","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib18","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1067\/mpd.2000.105150","article-title":"Kawasaki disease in older children and adolescents","volume":"137","author":"Stockheim","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib19","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1542\/peds.102.1.e7","article-title":"Kawasaki disease in the older child","volume":"102","author":"Momenah","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2013.06.040_bib20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1542\/peds.2003-0118-F","article-title":"Older age is a risk factor for the development of cardiovascular sequelae in Kawasaki disease","volume":"114","author":"Muta","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2013.06.040_bib21","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2165\/11631440-000000000-00000","article-title":"Epidemiology and management of Kawasaki disease","volume":"72","author":"Luca","year":"2012","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2013.06.040_bib22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1442-200X.2010.03161.x","article-title":"Case-control study of giant coronary aneurysms due to Kawasaki disease: the 19th nationwide survey","volume":"52","author":"Sudo","year":"2010","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jaad.2013.06.040_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00246-011-0143-1","article-title":"Assessment of risk factors for Korean children with Kawasaki disease","volume":"33","author":"Kim","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jaad.2013.06.040_bib24","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.humimm.2012.03.011","article-title":"Genetic susceptibility to Kawasaki disease: analysis of pattern recognition receptor genes","volume":"73","author":"Onoyama","year":"2012","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaad.2013.06.040_bib25","doi-asserted-by":"crossref","first-page":"e38998","DOI":"10.1371\/journal.pone.0038998","article-title":"Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic study","volume":"7","author":"Orenstein","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2013.06.040_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1203\/00006450-200301000-00120","article-title":"Predominance of monocytes and macrophages in the inflammatory infiltrates of acute Kawasaki disease arteritis","volume":"53","author":"Jennette","year":"2003","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaad.2013.06.040_bib27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1442-200x.2005.02049.x","article-title":"Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease","volume":"47","author":"Takahashi","year":"2005","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jaad.2013.06.040_bib28","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1086\/323155","article-title":"CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease","volume":"184","author":"Brown","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaad.2013.06.040_bib29","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/INF.0b013e31825eaed0","article-title":"Perinatal exposures and Kawasaki disease in Washington State: a population-based, case-control study","volume":"31","author":"Hayward","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2013.06.040_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1542\/peds.65.1.21","article-title":"National surveillance of Kawasaki disease","volume":"65","author":"Morens","year":"1980","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2013.06.040_bib31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2188\/jea.13.246","article-title":"Analyses of fatal cases of Kawasaki disease in Japan using vital statistical data over 27 years","volume":"13","author":"Hayasaka","year":"2003","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jaad.2013.06.040_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/archpedi.156.2.162","article-title":"Mortality among persons with a history of Kawasaki disease in Japan: the fifth look","volume":"156","author":"Nakamura","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jaad.2013.06.040_bib33","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00246-012-0186-y","article-title":"Incomplete and atypical Kawasaki disease: a clinicopathologic paradox at high risk of sudden and unexpected infant death","volume":"33","author":"Pucci","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jaad.2013.06.040_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1542\/peds.61.1.100","article-title":"Pathology of the heart in Kawasaki disease","volume":"61","author":"Fujiwara","year":"1978","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2013.06.040_bib35","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0022-3476(86)80928-3","article-title":"Myocardial infarction in Kawasaki disease: clinical analyses in 195 cases","volume":"108","author":"Kato","year":"1986","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib36","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00246-010-9838-y","article-title":"The 30-year outcome for patients after myocardial infarction due to coronary artery lesions caused by Kawasaki disease","volume":"32","author":"Tsuda","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jaad.2013.06.040_bib37","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1442-200X.2012.03628.x","article-title":"Rate, associated factors and outcomes of recurrence of Kawasaki disease in Ontario, Canada","volume":"54","author":"Chahal","year":"2012","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jaad.2013.06.040_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1001\/archpedi.1983.02140290003001","article-title":"Kawasaki syndrome in the United States 1976 to 1980","volume":"137","author":"Bell","year":"1983","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaad.2013.06.040_bib39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01.inf.0000202068.30956.16","article-title":"Kawasaki syndrome and risk factors for coronary artery abnormalities: United States, 1994-2003","volume":"25","author":"Belay","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2013.06.040_bib40","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2188\/jea.JE20090180","article-title":"Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey","volume":"20","author":"Nakamura","year":"2010","journal-title":"J Epidemiol"},{"key":"10.1016\/j.jaad.2013.06.040_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1651-2227.2001.tb00253.x","article-title":"Incidence rate of recurrent Kawasaki disease and related risk factors: from the results of nationwide surveys of Kawasaki disease in Japan","volume":"90","author":"Hirata","year":"2001","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib42","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1651-2227.1994.tb12986.x","article-title":"Incidence rate of recurrent Kawasaki disease in Japan","volume":"83","author":"Nakamura","year":"1994","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib43","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-3476(97)70038-6","article-title":"Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose","volume":"131","author":"Terai","year":"1997","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib44","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1542\/peds.88.6.1144","article-title":"Cardiac sequelae of Kawasaki disease in Japan: statistical analysis","volume":"88","author":"Nakamura","year":"1991","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2013.06.040_bib45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.06.040_bib46","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(84)91504-6","article-title":"High-dose intravenous gammaglobulin for Kawasaki disease","volume":"2","author":"Furusho","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.06.040_bib47","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1542\/peds.2011-1704","article-title":"Late intravenous immunoglobulin treatment in patients with Kawasaki disease","volume":"129","author":"Muta","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2013.06.040_bib48","first-page":"CD004000","article-title":"Intravenous immunoglobulin for the treatment of Kawasaki disease in children","volume":"4","author":"Oates-Whitehead","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2013.06.040_bib49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/CIRCGENETICS.112.963710","article-title":"Genetics insights into the pathogenesis of Kawasaki disease","volume":"5","author":"Burns","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.jaad.2013.06.040_bib50","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.pcl.2012.03.009","article-title":"Kawasaki disease","volume":"59","author":"Scuccimarri","year":"2012","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.jaad.2013.06.040_bib51","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(04)16814-1","article-title":"Kawasaki syndrome","volume":"364","author":"Burns","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.06.040_bib52","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/eji.201242398","article-title":"Anti-inflammatory effects of high-dose IgG on TNF-alpha-activated human coronary artery endothelial cells","volume":"42","author":"Matsuda","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaad.2013.06.040_bib53","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1399-3038.2010.01129.x","article-title":"Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production","volume":"23","author":"Tawfik","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaad.2013.06.040_bib54","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/s00246-012-0229-4","article-title":"Intravenous immunoglobulin counteracts oxidative stress in Kawasaki disease","volume":"33","author":"Kaneko","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jaad.2013.06.040_bib55","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jpeds.2012.02.048","article-title":"Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease","volume":"161","author":"Tremoulet","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib56","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0022-3476(96)70447-X","article-title":"Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids","volume":"128","author":"Wright","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpeds.2007.12.021","article-title":"Resistance to intravenous immunoglobulin in children with Kawasaki disease","volume":"153","author":"Tremoulet","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib58","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/00006454-199812000-00009","article-title":"Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US\/Canadian Kawasaki Syndrome Study Group","volume":"17","author":"Burns","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2013.06.040_bib59","first-page":"780","article-title":"Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease","volume":"47","author":"Sittiwangkul","year":"2006","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jaad.2013.06.040_bib60","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/INF.0b013e31815922b5","article-title":"Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan","volume":"27","author":"Uehara","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2013.06.040_bib61","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrrheum.2012.65","article-title":"Paediatric rheumatology: corticosteroids as primary therapy in Kawasaki disease","volume":"8","author":"Reindel","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaad.2013.06.040_bib62","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","article-title":"Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease","volume":"113","author":"Kobayashi","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jaad.2013.06.040_bib63","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jpeds.2010.10.031","article-title":"Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance","volume":"158","author":"Sleeper","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib64","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3349\/ymj.2012.53.2.262","article-title":"Kawasaki disease: laboratory findings and an immunopathogenesis on the premise of a \u201cprotein homeostasis system\u201d","volume":"53","author":"Lee","year":"2012","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jaad.2013.06.040_bib65","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/tropej\/fmh087","article-title":"High-dose intravenous immunoglobulin downregulates the activated levels of inflammatory indices except erythrocyte sedimentation rate in acute stage of Kawasaki Disease","volume":"51","author":"Lee","year":"2005","journal-title":"J Trop Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib66","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1542\/peds.80.6.828","article-title":"Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin","volume":"80","author":"Ichida","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2013.06.040_bib67","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0022-3476(84)80114-6","article-title":"Coagulopathy and platelet activation in Kawasaki syndrome: identification of patients at high risk for development of coronary artery aneurysms","volume":"105","author":"Burns","year":"1984","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib68","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1442-200X.1988.tb02498.x","article-title":"Studies on the effect of long-term use of low dose aspirin in Kawasaki disease","volume":"30","author":"Hamasaki","year":"1988","journal-title":"Acta Paediatr Jpn"},{"key":"10.1016\/j.jaad.2013.06.040_bib69","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial","volume":"379","author":"Kobayashi","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.06.040_bib70","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/heartjnl-2012-302126","article-title":"Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis","volume":"99","author":"Chen","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.jaad.2013.06.040_bib71","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1542\/peds.2011-0148","article-title":"Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial","volume":"129","author":"Ogata","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2013.06.040_bib72","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1067\/S0022-3476(03)00387-1","article-title":"Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children","volume":"143","author":"Okada","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib73","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJMoa061235","article-title":"Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease","volume":"356","author":"Newburger","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.06.040_bib74","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1067\/mpd.2003.191","article-title":"Corticosteroids in the initial treatment of Kawasaki disease: report of a randomized trial","volume":"142","author":"Sundel","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib75","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00431-011-1585-4","article-title":"A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease","volume":"171","author":"Zhu","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib76","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0022-3476(05)80972-2","article-title":"Gamma globulin re-treatment in Kawasaki disease","volume":"123","author":"Sundel","year":"1993","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib77","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/archpedi.154.7.694","article-title":"Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease","volume":"154","author":"Han","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jaad.2013.06.040_bib78","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jjcc.2008.08.002","article-title":"The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy","volume":"53","author":"Ogata","year":"2009","journal-title":"J Cardiol"},{"key":"10.1016\/j.jaad.2013.06.040_bib79","first-page":"338","article-title":"Methylprednisolone pulse therapy in Kawasaki disease [in Japanese]","volume":"66","author":"Miura","year":"2008","journal-title":"Nihon Rinsho"},{"key":"10.1016\/j.jaad.2013.06.040_bib80","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1179\/027249304225013330","article-title":"Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature","volume":"24","author":"Hung","year":"2004","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib81","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1253\/circj.72.850","article-title":"Infliximab treatment for refractory Kawasaki disease with coronary artery aneurysm","volume":"72","author":"Oishi","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.jaad.2013.06.040_bib82","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jpeds.2010.06.014","article-title":"Prospective open-label trial of etanercept as adjunctive therapy for kawasaki disease","volume":"157","author":"Choueiter","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib83","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jpeds.2008.06.011","article-title":"Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease","volume":"153","author":"Burns","year":"2008","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib84","first-page":"453","article-title":"Efficacy of infliximab in long-lasting refractory Kawasaki disease","volume":"24","author":"Zulian","year":"2006","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaad.2013.06.040_bib85","first-page":"808","article-title":"Infliximab as a novel therapy for refractory Kawasaki disease","volume":"31","author":"Weiss","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2013.06.040_bib86","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3899\/jrheum.110877","article-title":"Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series","volume":"39","author":"Mori","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaad.2013.06.040_bib87","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00246-011-0045-2","article-title":"Infliximab treatment for pediatric refractory Kawasaki disease","volume":"32","author":"Blaisdell","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jaad.2013.06.040_bib88","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jpeds.2010.10.012","article-title":"Infliximab for intravenous immunoglobulin resistance in Kawasaki disease: a retrospective study","volume":"158","author":"Son","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib89","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1399-3038.2010.01029.x","article-title":"Infliximab administration effective in the treatment of refractory Kawasaki disease","volume":"21","author":"Accomando","year":"2010","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaad.2013.06.040_bib90","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4070\/kcj.2010.40.7.334","article-title":"Infliximab treatment for refractory kawasaki disease in korean children","volume":"40","author":"Song","year":"2010","journal-title":"Korean Circ J"},{"key":"10.1016\/j.jaad.2013.06.040_bib91","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1546-0096-7-3","article-title":"Infliximab for the treatment of intravenous immunoglobulin resistant Kawasaki disease complicated by coronary artery aneurysms: a case report","volume":"7","author":"Brogan","year":"2009","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.jaad.2013.06.040_bib92","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s12098-008-0084-8","article-title":"Infliximab treatment in refractory Kawasaki syndrome","volume":"75","author":"Girish","year":"2008","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib93","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/0009922806294842","article-title":"Incomplete and atypical Kawasaki disease in a young infant: severe, recalcitrant disease responsive to infliximab","volume":"46","author":"O\u2019Connor","year":"2007","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jaad.2013.06.040_bib94","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jpeds.2005.07.039","article-title":"Infliximab for Kawasaki syndrome","volume":"149","author":"Saji","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib95","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/03009740600588228","article-title":"The effect of TNFalpha blockade in complicated, refractory Kawasaki disease","volume":"35","author":"Stenbog","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaad.2013.06.040_bib96","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jpeds.2004.12.022","article-title":"Infliximab treatment for refractory Kawasaki syndrome","volume":"146","author":"Burns","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib97","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/INF.0b013e3181e05564","article-title":"Primary treatment of incomplete Kawasaki disease with infliximab and methylprednisolone in a patient with a contraindication to intravenous immune globulin","volume":"29","author":"Shirley","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2013.06.040_bib98","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jcma.2011.09.001","article-title":"Recent advances in the treatment of Kawasaki disease","volume":"74","author":"Weng","year":"2011","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.jaad.2013.06.040_bib99","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cyto.2012.08.006","article-title":"Inflammatory cytokine profiles during Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease","volume":"60","author":"Hamada","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.jaad.2013.06.040_bib100","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3349\/ymj.2008.49.5.714","article-title":"Low-dose methotrexate therapy for intravenous immunoglobulin-resistant Kawasaki disease","volume":"49","author":"Lee","year":"2008","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jaad.2013.06.040_bib101","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1542\/peds.105.6.e78","article-title":"Initial intravenous gammaglobulin treatment failure in Kawasaki disease","volume":"105","author":"Wallace","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2013.06.040_bib102","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1007\/s00246-008-9221-4","article-title":"A case of refractory Kawasaki disease complicated by peripheral ischemia","volume":"29","author":"Kim","year":"2008","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/j.jaad.2013.06.040_bib103","first-page":"136","article-title":"Treatment of intravenous immunoglobulin-resistant Kawasaki disease with methotrexate","volume":"34","author":"Ahn","year":"2005","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.jaad.2013.06.040_bib104","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3349\/ymj.2002.43.4.527","article-title":"A case of intravenous immunoglobulin-resistant Kawasaki disease treated with methotrexate","volume":"43","author":"Lee","year":"2002","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jaad.2013.06.040_bib105","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/INF.0b013e318220c3cf","article-title":"Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin","volume":"30","author":"Suzuki","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2013.06.040_bib106","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1542\/peds.112.4.986","article-title":"Longstanding obliterative panarteritis in Kawasaki disease: lack of cyclosporin A effect","volume":"112","author":"Kuijpers","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2013.06.040_bib107","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00006454-200106000-00022","article-title":"Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy","volume":"20","author":"Raman","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jaad.2013.06.040_bib108","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1442-200X.2011.03487.x","article-title":"Long-term efficacy of plasma exchange treatment for refractory Kawasaki disease","volume":"54","author":"Hokosaki","year":"2012","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jaad.2013.06.040_bib109","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1744-9987.2008.00566.x","article-title":"A report of two cases of Kawasaki disease treated with plasma exchange","volume":"12","author":"Harada","year":"2008","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.jaad.2013.06.040_bib110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/s10165-003-0264-3","article-title":"Efficacy of plasma exchange therapy for Kawasaki disease intractable to intravenous gamma-globulin","volume":"14","author":"Mori","year":"2004","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.jaad.2013.06.040_bib111","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0140-6736(95)91916-3","article-title":"Plasma exchange in Kawasaki disease","volume":"346","author":"Takagi","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.06.040_bib112","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jpeds.2012.01.018","article-title":"Resistant Kawasaki disease treated with anti-CD20","volume":"160","author":"Sauvaget","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2013.06.040_bib113","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1136\/annrheumdis-2012-201658","article-title":"A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation","volume":"71","author":"Cohen","year":"2012","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213007123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213007123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:28:26Z","timestamp":1759271306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962213007123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":113,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0190962213007123"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.06.040","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kawasaki disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.06.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}